However, polymerase chain reaction amplification of DNAs from bone marrow, spleen, and peripheral blood showed no evaluated the long-term engraftment of retrovirally transduced bone marrow cells in nonmyeloablated hosts. Male evidence of the transduced MDR1 gene. RT-PCR analysis of total bone marrow RNA showed that transcripts from the bone marrow was stimulated in a cocktail of interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor ( 
H
ceiving 5FU-treated transduced cells 25, 26 indicates that integration occurs in a very early progenitor. The expression of EMATOPOIETIC PROGENITOR cells, because of their renewal capacity as well as multilineage contribution, are an ideal target for the delivery of gene therapy MDR1 in cells of the hematopoietic lineages should provide host resistance to a variety of chemotherapuetic agents. This for both disease treatment and genetic ''rescue.'' 1-3 Gene transfer into hematopoietic cells by retroviral transduction protects the marrow cells from the effects of the drugs and may allow safe delivery of greater therapeutic doses. Overexhas proven partially successful giving low-level and often short-term expression of the transduced genes both in human pression of the MDR1 gene, along with another therapeutic agent in a dicistronic vector would also permit the positive and animal models. The delivery of hematopoietic progenitor cells transfected with a foreign gene into myeloablated hosts, selection of progenitor cells in vitro or in vivo, which may be of special benefit when transplanting transduced cells into which received either substantial chemotherapy or irradiation, leads to marrow reconstitution and variable degrees of a normal host. In this report, using an MDR1 retroviral vector, we show gene expression.
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The capacity of hematopoietic progenitor cells to lead to a high rate of successful transduction of primitive hematopoietic cells in vitro by mRNA expression of the MDR1 substantial engraftment in normal nonmyeloablated hosts, gives rise to reasonable expectation that transduced progenitransgene in hematopoietic progenitor cell-derived colonies (multifactor responsive high proliferative potential-colony tor cells may be capable of delivering new gene sequences in a clinical or therapeutic situation where transplant without forming cells [HPP-CFCs] ). Additionally, we confirm the ability of transduced progenitor cells to engraft into the normyeloablation is desirable, such as in the case of genetic diseases or human immunodeficiency virus (HIV). A murine mal, nonmyeloablated host. transplant model, which shows reproducible engraftment ki-
MATERIALS AND METHODS
netics for normal bone marrow, has been well characterized and used extensively to establish the nature of the longBone marrow harvest. Bone marrow was harvested from the tibia and femur of male BALB/c mice (18-22 g, Charles River, term repopulating progenitor cells. [19] [20] [21] [22] The ability to deliver progenitor cells into a normal host provides the opportunity to assess the potential of transduced (retrovirally transfected) Wilmington, MA) as previously described. 19 Donors in the first co-7.5, 25 mmol/L EDTA [GIBCO Catalog #5577UA] with 0.75% 2-mercaptoethanol and 0.5% NP-40) was added to each sample, vorhort received 0.5 mg of recombinant murine stem cell factor (SCF; Genetics Institute, Cambridge, MA) in 100 mL of Dulbecco's Phostexed for 10 seconds, and 25 mL of 2 mol/L sodium acetate (pH 4.5) was added. Then each tube received 350 mL of 50% phenol/ phate-Buffered Saline (DPBS) by intraperitoneal (IP) injection 24 hours before collection of marrow. Cells were dispersed by pipetting 49% chloroform/1% isoamyl alcohol. Samples were vortexed for 10 seconds, ice chilled for 15 minutes, and microcentrifuged at 14,000 with a 10-mL pipette, nucleated-cell counts obtained in a 19:1 dilution with crystal violet, centrifuged at 1,200 rpm for 10 minutes, and rpm for 2 minutes. The RNA was precipitated with isopropanol for 4 hours at 020ЊC, microcentrifuged at 14,000 rpm for 15 minutes, resuspended in DPBS (GIBCO, Grand Island, NY) to the appropriate concentration.
drained, and dried in a Speed Vac Evaporator (Savant Instruments Inc, Holbrook, NY). Each pellet was resuspended in 200 mL of TE-MDR18.1 and N2-5 producer cell line. The cell line MDR18.1 produces the human MDR1 cDNA incorporated into an ecotropic NaCl (0.2 mol/L NaCl, 10 mmol/L Tris, 1 mmol/L EDTA, pH 7.2) then precipitated in 800 mL of ethanol for at least 4 hours at 020ЊC. retroviral vector driven by the Harvey murine sarcoma virus long terminal repeats, 24, 27 and the N2-5 cell line produces vector that RNA samples were pelleted at 14,000 rpm for 15 minutes, dried, and then resuspended in 44 mL of sterile pure water (GIBCO) for contains the Neomycin resistance gene (both obtained from David Bodine, National Institutes of Health, Bethesda, MD). The MDR18.1 use.
The reverse transcriptase (RT) reaction was performed using 10 and N2-5 cell lines were maintained at 37ЊC 5% CO 2 in growth medium: Dulbecco's modified Eagle's medium (DMEM) low glumL of the colony RNA added to 14.5 mL of PCR-grade water, 3.5 mL of 10 U/mL RNasin (Promega, Madison, WI), and 2 mL of 10 cose (GIBCO), 4 mmol/L glutamine (GIBCO), penicillin-streptomycin (GIBCO), and 15% heat-inactivated newborn (less than 10 days) nmol/L random primers (GIBCO). After heating at 70ЊC for 5 minutes, samples were ice chilled and to each was added 3.5 mL of bovine serum (GIBCO).
Incubations (prestimulation and transduction). Bone marrow RNasin at 10 U/mL, 13 mL of 10X SSRT buffer (GIBCO), 17.5 mL of 2 mmol/L dNTPs, and 1 mL of SSRTII RT (GIBCO). Samples cells were cultured at 1 1 10 6 /mL in infection medium: DMEM low glucose (GIBCO), 4 mmol/L glutamine (GIBCO), penicillinwere heated to 42ЊC for 60 minutes, heated to 70ЊC for 5 minutes, and then either stored at 020ЊC or processed immediately in the streptomycin (GIBCO), and 15% heat-inactivated fetal bovine serum (Hyclone, Logan, UT) in Corning (Corning Inc, Corning, NY) sus-PCR reaction.
The PCR amplification reaction of the cDNA was performed on pension dishes (#25070-100). The 48-hour prestimulation was done in medium alone or in the presence of a cytokine cocktail, which one third of each RT reaction (20 mL), allowing for sufficient template to run duplicate samples and a control, usually a ''no-primer'' contained 50 U/mL of interleukin-3 (IL-3), 50 U/mL IL-6, 50 ng/ mL recombinant human IL-11 (Genetics Institute), and 50 ng/mL reaction, for each colony. The modified ''hot-start'' PCR reactions contained template and primer in the bottom layer, a layer of paraffin recombinant murine SCF. Cells were harvested and resuspended in a small volume of DPBS. Cells were cocultured with retroviral wax (Wax Gem 100, Perkin Elmer-Cetus, Norwalk, CT), and the reaction mix containing buffer, nucleotides, and enzyme on the top. producer cells for 24 hours in the same medium and cytokine mixture as the prestimulation at the same concentration (1 1 10 6 /mL). PolyPrimers were used at a final concentration of 1 mmol/L and final reaction conditions were 50 mmol/L KCl; 10 mmol/L Tris-HCl pH brene (Hexadimethrine Bromide from Sigma, St Louis, MO) was added to the retroviral cocultures at a final concentration of 6 mg/ 8.3; 3.25 mmol/L MgCl 2 ; 0.2 mmol/L each dATP, dCTP, dGTP, and dTTP; AmpliTAQ TAQ polymerase (Perkin Elmer), and 4 mCi mL.
HPP-CFC assay. Bone marrow cells (control or transduced) 32 PdCTP (NEG-O37Z, NEN; DuPont, Wilmington, DE). PCR used 35 cycles of 94ЊC for 1 minute, 55ЊC for 1 minute, and 72ЊC for 2 were plated in the HPP-CFC assay as previously described. 28, 29 Briefly, for each 35-mm dish 25,000 or 50,000 cells are plated into minutes. Primers used for PCR 24 : MDR (upstream) 5-GCC CAC ATC ATC ATG ATC-3; MDR (downstream) 5-GTC TCC TAC the top agar layer (0.5 mL) over a bottom feeder layer of agar, medium, and cytokines (1.35 mL). The cytokine mixture used for TTT AGT GCT-3. For analysis, samples were resolved on a 5% acrylamide gel and bands were measured by ultraviolet (UV) this in vitro hematopoietic progenitor colony assay is given as the concentration in the underlayer, and the final concentration for the shadow, then gels were dried onto 3MM Whatman paper (Whatman International, Kent, UK) and exposed to radiography film. entire dish is listed in brackets after. The 6-factor plates contained 52,000 U [38,000 U] human colony-stimulating factor-1 (CSF-1;
Transplant into nonmyeloablated hosts. Plates were incubated at 37ЊC, high humidity, 5% oxygen, and 10% for 5 days, same volume as cell infusions). Mice were given 10 mg/ kg TAXOL (IP) at three times over a 14-month period. TAXOL CO 2 for 7 to 14 days. The HPP-CFC was defined as a tight ball of cells at 14 days of greater than 0.5 mm in diameter or a dense colony was supplied by Bristol Myers/Squibb (Princeton, NJ), and delivered at 5 and a half months, 9 and a half months, and 13 months posttransgreater than 1.0 mm in diameter.
Colony reverse transcriptase-polymerase chain reaction (RTplant. Animals were sacrificed and analyzed 2 weeks after the last TAXOL injection. PCR) assay. Individual, nonoverlapping HPP-CFC colonies were picked from the agar using a solution of sterile water with 0.2
Analyses of transplant recipients. The DNA from tissues and organs was analyzed by Southern blot for the presence of Y chromomg/mL brewers yeast tRNA (Boehringer Mannheim, Mannheim, Germany). Colony RNA was prepared by a variation of the method some specific sequences as previously described. 19 Briefly, DNA was digested with Dra I restriction endonuclease, resolved on 0.8% of Witesell and Schook. 30 Briefly, 200 mL of a guanidine isothiocya- we selected 51 colonies. Cells were plated in either 6-factor by Southern blot; however, the analysis was extended to include (n Å 53 colonies selected), 7-factor (n Å 64 colonies sea more sensitive PCR assay using MDR1-specific primers (listed lected), or high-CSF-1 (n Å 81 colonies selected) agar bipreviously) and an internal reaction and copy number control for layers for 7 or 14 days. All colonies combined (n Å 99) cells into the normal marrow microenvironment, the male surrogate representing a multilineage hematopoietic progenibone marrow cells were collected after transduction and intor/stem cell population that correlates with marrow rejected into normal nonmyeloablated female BALB/c hosts newal. 28, 29 The HPP-CFC is the predominant cell, apin a solution of DPBS. Mice were followed for 14 months proaching 100%, in certain ''purified'' stem cell populations posttransplant by PCR of peripheral blood before and after including the Hoechst low Rhodamine low lineage negative each of the three TAXOL (10 mg/kg IP) injections, using cells 34 indicating that it is an in vitro surrogate for an early MDR-specific primers. At each time point, all PCR analyses hematopoietic progenitor cell population. We have chosen of peripheral blood samples were negative for MDR1 provito use the HPP-CFC assay, which represents an early progenral sequences. At 14 months, 2 weeks after the third Taxol itor and which lends itself easily to colony RT-PCR analysis.
injection, host tissues were harvested and analyzed for both The HPP-CFC plating assay routinely includes six cyto-Y-specific sequence and presence of the MDR provirus. kines (SCF, CSF-1, IL-1a , IL-3, G-CSF, and GM-CSF), Analysis of bone marrow by FISH, using a male-specific and often basic FGF is added as well. Transduction of these probe showed donor (ie, male) engraftment of the ex vivo progenitors was determined by RT-PCR of individual colomanipulated marrow. The engraftment as determined by Ynies to detect RNA from the transferred human MDR1 gene.
chromosome FISH shows engraftment levels between 8.9% Figure 1A shows examples of RT-PCR using MDR1 primers and 13.4%. Slides were visually scored by three different and RNA from HPP-CFC colonies. The cDNA from each investigators and then averaged. Southern blot with phoscolony RT reaction is split into thirds, allowing for one phorimage image analysis, resulted in calculated engraftment control reaction and duplicate analytical reactions. The colovalues that were close to, but not identical to those obtained nies selected for analysis had opaque centers 1.0 to 2.0 mm in by FISH: TX1 9.1%, TX2 7.0%, TX5 6.5%, TX6 7.1%, and diameter. Additionally, a group of differentiated macrophage TX40 and TX60 0%. Results are summarized in Table 1 . colonies, grown in serum plus CSF-1, was screened and 50% Engraftment in host splenic tissues from the same mice when showed expression of the MDR1 mRNA (Figs 2 and 3) . The determined by Southern blot was lower than in bone marrow: primers used are located upstream of a cryptic splice site TX1 4.2%, TX2 0.6%, TX5 0.7%, and TX6 2.9%. in the MDR1 cDNA, thereby avoiding detection problems PCR amplification was used to detect the presence of associated with the shortened mRNA that is sometimes gen-MDR1 proviral DNA; this showed no detectable MDR1 erated (D. Bodine, personal communication); in our hands DNA in the peripheral blood taken before and after each this is not a problem as we get mRNA and protein expression Taxol challenge. Additionally, there was no MDR1 DNA from the transgene. The routine positive and negative condetected in the bone marrow or spleen tissues harvested at trols that are needed for this assay are shown in Fig 1B. 14 months (Fig 4) . Using RT-PCR to detect expression of The colony RT-PCR assay reproducibly detects the RNA mRNA we did detect the MDR1 mRNA in bone marrow, transcript from the human MDR1 cDNA. Controls show no although at very low levels as shown in Fig 5. From a dilusignal from the possible sources of background, eg, mouse tion curve prepared with MDR-transduced cells mixed with RNAs, tRNA carrier, and agar from between colonies.
noninfected cells, we estimate the number of cells producing We analyzed 99 bone marrow HPP-CFC colonies from MDR transcript to be between 1 in 10,000 and 1 in 100,000. cells transduced using the MDR18.1 retroviral producer line in the presence of the four cytokine cocktail (IL-3, IL-6, ILWe conclude that our low expression of the transgene was AID not a result of gene ''shut-off'' because the proviral DNA ered human MDR1 gene. In excess of 88% of HPP-CFC produce mRNA for the transgene. This colony assay reflects a was not detected. Rather the transgene is present and exprimitive pluripotential population of hematopoietic cells, which pressed in only a small number of engrafted donor cells.
correlates with host marrow repopulation, 34 and we conclude Although this demonstration is not stringently quantitative, that standard transduction procedures, which use ex vivo culture it is an exciting confirmation that successfully transduced and cytokines to facilitate retroviral integration, are successful cells were engrafted in the normal host.
in transfecting this primitive cell population. The nonablated bone marrow microenvironment may conlong-term in vivo engraftment can be effectively transduced.
stitute a qualitatively different engraftment site than the These data show that transduced hematopoietic cells express-''empty'' or altered marrow resulting from chemotherapy or ing the human MDR1 gene are capable of long-term enradiation. In an ablated marrow, repopulation is essentially graftment in a nonablated host marrow. This has exciting oligoclonal, the result of expansion of a small subpopulation applications for gene therapy of genetic disorders and disof engrafted progenitors. The use of nonmyeloablated hosts eases such as HIV that do not necessitate destruction of the was initally reported by Brecher et al 22 and has been subsehost bone marrow.
quently used to characterize the functional status of engrafting hematopoietic stem cells. [19] [20] [21] 35 Using this model, donor progenitor cell engraftment has been reproducibly shown to be truly competitive in this environment. Donor 13.4 7.1
Bone marrow from each transplant recipient was assayed for the percent of donor cell composition. The experiment label for each animal appears in the first column (TX1, TX2, TX5, TX6). The total number of male bone marrow cells injected into each female is listed (FISH) assay is produced with a Y-chromosome-specific painting are then further divided, along the horizontal axis, into the colony probe. To determine the percent male, the number of cells positive assay conditions in which they were grown, HPP-CFC (6 or 7 factor) by FISH was divided by the total number of cells in each sample. and high-CSF-1. The number of colonies in each group appears in Total cell counts were obtained by staining nuclear chromatin of all parentheses. The percent positive is listed in bold in each section.
cells with 4,6-Diamidino-2-phenylindole (DAPI). Several entire fields This illustrates the efficient transfer of the vector into the HPP-CFC were counted for each group (136 to 480 cells/group) by three individregardless of transduction conditions or plating assay; colonies are uals and the results were averaged. Bone marrow DNA from each 83% to 97% positive. Interestingly, both transduction conditions remouse was analyzed by Southern blot using the PY2 plasmid. 29 The sulted in lower transfer into the macrophage colonies; 45% were resulting donor engraftment values for whole bone marrow DNA are positive from the four cytokine transductions and 57% were positive from the transduction in medium alone.
presented in column four.
AID Blood 0019 / 5h39$$$361 06-12-97 00:41:13 blda WBS: Blood score divided by control score) significance value of 2.000 The donor cell engraftment levels are in an acceptable (data not shown). This lack of detectable immune system range for use in gene transfer procedures in nonablated hosts recognition or response to human MDR1 indicates that fail-(8% to 10%). The number of progenitor cells that are transure of MDR1 transduced marrow to engraft in the nonablated duced with the MDR1 gene is also within a range that would host is probably not related to host immunity. facilitate efficient gene transfer, as shown by the high rate Cytokine-stimulated proliferation is implicated as the of HPP-CFC scoring positive for MDR1 mRNA. However, the number of effectively transduced progenitor cells that engrafted is quite low. These data suggest that the majority of progenitor cells that integrated the MDR1 gene failed to engraft and that, of the cells that did engraft, only a small fraction had integrated the transgene. Thus, we propose that exposing the donor bone marrow to the retroviral transduction procedure impairs engraftment of transduced hematopoietic progenitors in the nonablated host.
To facilitate retroviral gene insertion, hematopoietic target cells are frequently stimulated to proliferate in vitro with cytokines. Cytokine stimulation induces the cell cycle transit necessary for successful proviral integration into the geno- For personal use only. on May 3, 2017. by guest www.bloodjournal.org From mechanism that induces a functional change in the progenitor short viral incubation times without cytokines have achieved expression of the transgene in children. 45 Although this incells that is related in some way to their cell-cycle status. This cell cycle related engraftment defect has been shown cluded introduction into an ablated marrow, it does suggest that in vitro incubation with cytokines before stem cell transin nonablated hosts, as well as irradiated hosts. 20, 35, 44 Interestingly, in these studies that used the cytokine incubation to plant may be unnecessary. This report establishes the transfer of the human MDR1 facilitate retroviral integration, we achieved superior levels of engraftment to those reported previously by Peters et gene into the nonmyeloablated murine host. Whereas the demonstration of gene transfer in this model has exciting al. 35, 44 The retroviral transduction begins with the same cytokine incubation but is then followed by a 24-hour coculture implications for gene therapy, the importance of maintaining engraftment potential is strongly emphasized. These studies with the retroviral producer cell line that is of murine fibroblast origin. We speculate that this might offer the progenitor show that stimulation of cell proliferation as a means to facilitate retroviral vector integration results in an encells a needed cellular factor (conditioned medium) or simply be the result of cell-cell contact. It is an exciting possibilgraftment defect that corresponds to the induction of cell cycle transit. We conclude that this gene-delivery system is ity for providing an atmosphere that either maintains or even reestablishes engrafting potential. To this end, many gene capable of transducing hematopoietic stem/progenitor cells, but that a relatively small fraction of these cells are capable transfer protocols are investigating the use of autologous stromal components during ex vivo gene transfer. Transfer of engrafting and contributing to the hematopoietic system of a nonmyeloablated host under the conditions of these into a nonmyeloablated canine host was achieved with transduced long-term bone marrow cultures; the transduction of experiments. Maintaining the engraftment potential, either by culture in a suitable microenvironment or by reversing cells cultured on autologous stroma resulted in retention of engraftment ability. 9 This manner of transduction, along with the loss of engraftment potential, will be an important step in applications of hematopoietic stem cell transplantation other approaches, may be critical to maximizing the number of long-term progenitors that retain engraftment potential and gene transfer. while being effectively transduced.
